stable coronary artery disease
Conditions
Interventions
healthy human group:Practicing the first phase of Buanduanjin exercise, including resting state before exercise in 3min, the preparatory, from the first to the eighth form and closed form in 12min, an
stable coronary artery disease group:Practicing from the first to the second phase of Buanduanjin exercise, including resting state before exercise in 3min, repeating the preparatory, from the first t
Sponsors
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 79 Years
Inclusion criteria
Inclusion criteria: 1. Healthy human: (1) Aged 35 to 79 years; (2) BMI 19 to 24[BMI=weight(kg)/height2(m2)]; (3) Without heart, liver, lung, kidney and other important organ diseases,without digestive system, respiratory system, circulatory system, blood system, endocrine system, nervous system and mental disorders; (4) No positive signs of clinical significance by physical examination; (5) Submitted informed consent. 2. Patients with stable coronary heart disease: (1) Aged 35 to 79 years; (2) Compliance with diagnostic criteria of stable coronary heart disease; (3) Classification of CCS cardiac function beween I-III; (4) Submitted informed consent.
Exclusion criteria
Exclusion criteria: 1. Healthy human: (1) Unable to exercise due to limb disorders or other reasons; (2) Women in pregnancy or lactation; (3) Other situations that researchers considered not suitable for the trial. 2. Patients with stable coronary heart disease: (1) Left main coronary artery stenosis; (2) Uncontrolled hypertension or systolic pressure=160mmHg and/or diastolic pressure=100mmHg after taken medicine; (3) Uncontrolled rapid arrhythmias with symptoms or hemodynamic disorders; (4) High or complete atrioventricular block; (5) acute endocarditis; (6) Obstructive hypertrophic cardiomyopathy; (7) Symptomatic severe aortic stenosis, decompensated heart failure, acute pulmonary embolism, deep vein thrombosis, acute pericarditis, myocarditis and acute aortic dissection; (8) Chronic pulmonary disease with dyspnea; (9) Stroke or transient ischemic attack with cognitive impairment in the short term; (10) The clinical problems that have not been corrected, such as infection, severe anemia, electrolyte disorder, hyperthyroidism, etc; (11) The abnormal function of liver and kidney (serum alanine aminotransferase or creatinine > 2 times the upper limit of normal reference value); (12) Unable to exercise due to limb disorders or other reasons; (13) Women in pregnancy or lactation; (14) Other situations that researchers considered not suitable for the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| metabolic equivalent; | — |
Secondary
| Measure | Time frame |
|---|---|
| oxygen uptake (VO2);VO2/kg;VO2/HR;carbon dioxide output(VCO2);minute ventilation(VE);VCO2/VO2;tidal volume(VT);respiration frequency(Rf);VE/VCO2;VE/VO2;the end-tidal CO2 pressures(PetCO2);st-segment deviation;heart rate recovery in 1min (HRR1);Borg Scale; | — |
Countries
China
Contacts
Public ContactWang Xianliang
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed